We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Cardiology

Journal Scan / Research · October 21, 2021

Unguided De-Escalation From Ticagrelor to Clopidogrel in Stabilized Patients With Acute Myocardial Infarction Undergoing PCI

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial
Lancet 2021 Oct 09;398(10308)1305-1316, CJ Kim, MW Park, MC Kim, EH Choo, BH Hwang, KY Lee, YS Choi, HY Kim, KD Yoo, DS Jeon, ES Shin, YH Jeong, KB Seung, MH Jeong, HW Yim, Y Ahn, K Chang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading